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FREQUENCIES  OF MITOGEN-REACTIVE  B  CELLS IN THE 
MOUSE 
II.  Frequencies of B  Cells Producing Antibodies Which Lyse Sheep or 
Horse Erythrocytes, and Trinitrophenylated or Nitroiodophenylated 
Sheep Erythrocytes 
BY JAN ANDERSSON,  ANTONIO  COUTINHO,  AND FRITZ MELCHERS 
(From the Biomedicum, University of Uppsala,  Uppsala, Sweden and the Basel Institute for 
Immunology, Basel, Switzerland) 
The  capacity of a  B  cell to  grow and to  mature into Ig-secreting, plaque- 
forming cells (PFC) ~  depends on its mitogen reactivity, i.e. to possess a receptor 
for a B-cell mitogen (1). Mitogen receptors must be distinct from Ig molecules on 
the surface of B cells, but they may be functionally and structurally associated 
with each other (2, 3). Every third B cell in the spleen of 6- to 8-wk old C3H/Tif 
mice has been found (4) to be reactive to the B-cell mitogen bacterial lipopolysac- 
charides  (LPS)  (5,  6)  and  approximately every fourth to  the  B-cell  mitogen 
lipoprotein (7). Each mitogen-reactive B cell yields a clone of cells which secrete 
one set of variable (v) regions on Ig molecules and, therefore, Ig molecules with 
a given specificity for antigen. Therefore, mitogenic stimulation results in PFC 
secreting the  entire  repertoire of sets  of v  regions  expressed  in  the  pool  of 
mitogen-reactive B cells. Since at least every third B cell in spleen is stimulated 
by LPS and lipoprotein this repertoire of stimulated clones of PFC may be a 
representative sample of the total repertoire of sets of v regions in all B cells. 
The culture conditions which let every third murine splenic B cell develop in 
vitro into a clone of IgM-secreting PFC depend on the presence of 2-mercaptoeth- 
anol, a growth-supporting fetal calf serum, growth-supporting thymus cells, and 
a growth- and maturation-inducing B-cell mitogen, e.g. LPS or lipoprotein. The 
clones of Ig-secreting PFC  can be assayed for their antigen specificities by a 
series of antigen-specific assays. In this paper, we have used a plaque assay for 
cells secreting hemolytic antibody to determine the number of mitogen-reactive 
B cells giving rise to clones of cells secreting antibody which, in the presence of 
complement, lyse sheep erythrocytes, horse erythrocytes, trinitrophenylated- or 
nitroiodophenylated sheep erythrocytes. In parallel,  we have enumerated all 
clones of IgM-secreting cells  in  a  modified hemolytic plaque  assay which is 
independent of v-region specificities (7). 
1Abbreviations  used  in this paper:  B,  bone marrow-derived, bursa equivalent; HRC,  horse 
erythrocytes; Ig, immunoglobulin;  LPS, bacterial lipopolysaccharides;  NIP, nitroiodophenyl;  PFC, 
plaque-forming cells;  SpA,  staphylococcus  protein A; SRC,  sheep  erythrocytes; T,  thymus-de- 
rived; TNP, trinitrophenyl; v, variable. 
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Materials  and Methods 
Animals.  C3H/Tif/BOM-mice, 6- to 8-wk of age, were obtained from Gr. Bomholtg~ard,  Ry, 
Denmark.  Lewis strain rats, 4 wk of age were obtained from the Institut fiir Biologisch-Medizin- 
ische Forschung AG, Fiilliusdorf, Switzerland. 
Cells.  Spleen cells, and  growth-supporting  thymus cells were prepared  as described in the 
preceding publication  (7).  Rat thymus cells were used in all experiments as growth-supporting 
cells. 
Culture Medium and Mitogens.  Spleen cells in growth-supporting thymus cells (3 x  10  e cell/ 
ml)  were  grown  in  RPMI  1640 medium  (Grand  Island  Biological Co.,  Grand  Island,  N.  Y.) 
containing 2-mercaptoethanol (5 ×  10 -~ M), fetal calf serum (10%, BioCult, Irvine, Scotland batch 
K  255701 D), and a  B-cell mitogen in 5-ml plastic tubes in 0.2-ml aliquots (Falcon 2058; Falcon 
Plastics, Oxnard, Calif.) (see preceding publication). LPS-S (EDTEN 18735 and $435/188049)  was 
kindly prepared for us by Doctors C. Galanos and O. Lfideritz, Max Planck Institut f~ir Immun- 
biologie, Freiburg i.  Br.,  West Germany.  It was used at 50  ~g/ml in culture. Escherichia coli 
lipoprotein (8), a  gift of Dr. V.  Braun,  Mikrobiologie II, Universi~t Tiibingen, Ttibingen, West 
Germany, was used at 2 ~g/ml. 
Plaque Assays for Ig- and Antibody-Secreting Cells.  For the detection of all cells secreting IgM 
a  modified hemolytic plaque  assay  (9)  was  used  which  employs protein  A  (SpA)-coated sheep 
erythrocytes  (SRC)  and  rabbit  (anti-mouse  IgM)  antibodies  as  developing  antibodies  in  the 
presence of properly diluted complement  (BioCult).  The IgM-specific antibodies were those de- 
scribed in the preceding publication.  Protein A  used in the coating of SRC was obtained from 
Dr. H. Wigzell, Biomedicum, University of Uppsala,  Uppsala,  Sweden. 
Direct PFC  with  SRC,  horse  erythrocytes  (HRC),  trinitrophenyl  (TNP)-SRC  and  nitroiodo- 
phenyl (NIP)-SRC were measured as described in previous publications  (3, 6). TNP-groups were 
coupled to SRC by the method of Rittenberg and Pratt (10) with 30 mg or with 3 mg trinitrobenzene 
sulfonic acid per ml of packed, washed SRC. They are referred to as TNP3o SRC and TNPs SRC in 
the Results. NIP-groups were coupled to SRC by the method of Pasanen and Miikelii (11) with 12 or 
1 mg NIP-azide per ml packed, washed SRC. They are referred to as NIP12 SRC and NIP1 SRC in 
the Results.  NIP-azide was kindly prepared for us by Dr. H.-R. Kiefer from our Institute. 
Results 
In  all  antibody  determinations,  the  definition  of specificity  is  set  by the 
detection  assay.  In  these  experiments  we  define  as  specific  antibodies  those 
which form hemolytic plaques in a Jerne-type assay. 
All frequency determinations were done in vitro, at cell concentrations limit- 
ing the number of clones detected in the various plaque assays to around one per 
culture.  According to Poisson's distribution,  one B-cell precursor producing  a 
clone with a given specificity is present in that number of cells per culture which 
let 63% of all cultures appear positive in the assay. 
Spleen cells were diluted first in 3.3-fold dilutions, from 1 × 10  s cells to one cell 
per culture, and grown in the presence of a constant number of growth-support- 
ing rat thymus cells (3 ×  106 per ml) and a growth-inducing mitogen, either LPS 
or lipoprotein.  10 cultures  were assayed for each cell  concentration  on  seven 
different target erythrocytes in the plaque assay, detecting clones secreting:  (a) 
IgM, with protein-A-SRC and a rabbit anti-mouse IgM as developing serum, (b) 
SRC,  (c)  HRC,  (d)  TNP3o-SRC,  (e)  TNP3-SRC,  (f) NIP,2-SRC,  and  (g)  NIP,- 
SRC. Since the doubling time in clones of mitogen-reactive B cells is 18 h  (4), 
each  clone  contains,  at  day  5  of culture,  around  30-60  cells.  Therefore,  all 
cultures were assayed at day 5 and all those containing more than 15 PFCs were 
scored as positive, responding cultures. These screening experiments yielded the 1522  FREQUENCIES  OF  ANTIGEN-SPECIFIC  B  CELLS 
TABLE  I 
LPS- or Lipoprotein-Stimulated B-CeU PFC Responses  Detected with Seven Different Plaque 
Assays at Different  Concentrations  of Spleen Cells Cultured in the Presence of Growth- 
Supporting Thymus Cells* 
Numbers of PFC per culture* 
Number of  Mitogen: LPS  Mitogen: lipeprotein 
spleen cells  SpA-  SpA- 
per culture  SRC/anti  NIP~SRC  TNPaoSRC  NIP~SRC  TNP~SRC  HRC  SRC  SRC/anti  TNP~SRC 
IgM  IgM 
SRC 
200,000  >2,000  >2,000  >2,000  >2,000  >2,000  >2,000  1,050  >2,000  >2,000  450 
60,000  >2,000  >2,000  >2,000  >2,000  >1,000  600  210  >2,000  >2,000  80 
20,000  >2,000  >2,000  >1,000  >1,000  750  185  65§  >2,000  >2,000  35§ 
6,000  >2,000  >2,000  550  370  180  55}  30§  >2,000  900  15§ 
2,000  >2,000  >1,000  185  180  80§  20}  <10  >2,000  210  <10 
600  >1,000  520  65§  40§  25§  <10  <10  >1,000  65  <10 
200  900  135  25§  <10  <10  <10  <10  600  15  <10 
60  250  35§  <10  <10  <10  <10  <10  200  <10  <10 
20  100§  <10  <10  <10  <10  <10  <10  75§  <10  <10 
6  25§  <10  <10  <10  <10  <10  <10  20§  <10  <10 
* 3 ×  10  e rat thymus cells/ml. 
* Assay at day 5 of culture,  average of 10 cultures. 
§ Individual cultures fluctuating  with either less than 10 PFC or more than 15 PFC, many ~60 PFC. 
approximate  number  of cells  per  culture  limiting  the  number  of  antibody 
producing clones to one, detected in the different plaque assays (Table I). 
In  the  range  of cell  concentrations  where  antibody-producing  clones  were 
found to become fluctuating,  indicating that the mitogen-reactive B cells pro- 
ducing antibodies with the tested specificities had become limiting, more narrow 
differences of cell concentrations were tested. Routinely, 40 cultures each were 
set up at 7-10 different cell concentrations within a  range yielding between 10 
and 90% nonresponsive cultures with the given plaque assay. At these limiting 
cell concentrations  cultures were often found to contain around 60 PFC when 
assayed at day 5.  Fig.  1 shows the distribution of clone sizes of IgM-secreting 
PFC which lyse SRC, determined in individual cultures containing numbers of 
reactive B  cells limiting  the SRC-specific clones to one,  i.e.  between 500  and 
10,000 spleen cells per culture (see also Fig. 2). It is evident that the distribution 
is discontinuous and that a clone arising from one SRC-specific, LPS-reactive B 
ceil contains  approximately 60 PFC.  Such clone sizes were expected from our 
previous results  (1,  4),  showing that  B  cells divide every 18 h  and that  every 
growing  B  cell  within  a  clone  at  day  5  of culture  secreted  enough  Ig  to be 
detected in the plaque  assay.  The logarithm  of the fraction  of nonresponding 
cultures obtained at the different cell concentrations  was then plotted against 
these cell concentrations in culture.  Figs.  2A and 2B summarize the results of 
these experiments  assayed with the seven different target erythrocytes in the 
plaque assay. 
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FIG.  1.  Distribution ofthe number of direct SRC-specific IgM-secreting PFC in individual 
cultures of C3H/Tif splenic B cells grown in the presence of 50 ~g/ml LPS and 3  x  10  e rat 
thymus cells/ml. The total number of IgM-secreting, SRC-specific PFC was determined at 
day 5 of culture. One square represents one culture. Data are the cummulated values of all 
frequency determinations for SRC-specific B cells shown in Fig. 2 A. 
with increasing numbers of cells in cultures was observed in all cases for B-cell 
clones stimulated by either LPS or lipoprotein.  This indicated that all B cells, 
stimulated by the two B-cell mitogens to clones of secreting cells, as detected in 
the seven different plaque assays, were limiting in the cultures. The number of 
cultured cells containing one B-cell precursor, developing into a clone producing 
antibody of the specificity set by the plaque assay was extrapolated from these 
data in Fig. 2 as that number of cells with which 37% of all cultures did not yield 
a  positive response.  These frequency determinations  are summarized in Table 
II. 
Since we can detect all IgM-secreting clones by the protein A plaque assay, we 
can calculate the absolute frequencies of specific B-cell clones in a  given mito- 
gen-reactive B-cell population. This is simply done by dividing the frequency of 
precursors  giving  a  specific clone by the  frequency of mitogen-reactive  IgM- 
secreting cells (Table II). 
We conclude from these data that the expected (1, 4) numbers of splenic B cells 
were stimulated to clones of IgM-secreting PFC by LPS (one of three B cells) or 
by lipoprotein (one of four to five B cells) (see preceding publication).  LPS- and 
lipoprotein-reactive B cells appear to contain approximately the same number of 
B  cells  producing  antibody  detected in  the  SRC  and  the  TNP30  SRC  plaque 
assays. Higher coupling densities on SRC of TNP- and of NIP-haptenic groups 
yielded,  as expected (2,  11),  higher frequencies for B cells producing antibody 
detected in these plaque assays. 
Discussion 
The two B-cell mitogens,  LPS and lipoprotein,  each stimulate every third to 
fourth  B  cell in spleen of 6- to 8-wk old C3H/Tif mice,  to clonal  growth and 1524 
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FIG. 2A.  Titration  of  LPS-  and  oflipoprotein  reactive  B cells  in  C3H/Tif  spleen.  Cells  were 
grown in  the presence of  50/~g/ml LPS and 3 x 106  rat  thymus cells/ml.  Each point  in  the 
Figure is  based on assays of  40 cultures.  The assays were done (a)  for  total  IgM-secreting 
PFC on  protein  A-SRC plus  anti  IgM-antibodies,  (b)  as  well  as  for  TNP3o SRC- (c)  for  SRC- 
and (d)  for  HRC-specific B-cell  clones  by  the  appropriate  plaque assays on  day 5  of  culture. 
Vertical  bars represent 95% confidence  limits. 
Fzo. 2B.  Titration  of  LPS-reactive B cells  in  C3H/Tif  spleen,  yielding  clones  of  TNP- and 
NIP-specific  PFC as assayed on SRC coupled with different  densities  of  TNP- and NIP- 
determinants. Conditions for  the experiments  are those  described  in  the legend of  Fig.  2A. 
Vertical  bars represent 95% confidence  limits. J.  ANDERSSON,  A.  COUTINHO,  AND  F.  MELCHERS  1525 
TABLE  II 
Frequencies of LPS- and of Lipoprotein-Reactive  B Cells Producing Immunoglobulin 
Molecules Detected in Seven Different Plaque Assays 
Plaque assay  Mitogen 
Approximate fre-  Frequency* per  quency* per B cells 
total spleen cells  in spleens 
Frequency* of 
specific B cells 
within the popu- 
lation of mito- 
gen-reactive B 
cells§ 
Protein A-SRC and anti  LPS  1 in 6  -1 in 3 
IgM-developing anti-  Lipoprotein  1 in 8  ~1 in 4 
bodies 
NIP,2SRC  LPS  1 in 57  ~1 in 30  1 in 10 
TNP3oSRC  LPS  1 in 280  -1 in 150  1 in 50 
Lipoprotein  1 in 400  -1 in 200  1 in 50 
NIP1SRC  LPS  1 in 600  -1 in 300  1 in 100 
TNP3SRC  LPS  1 in 960  -1 in 500  1 in 160 
HRC  LPS  1 in 2,900  -1 in 1,500  1 in 500 
SRC  LPS  1 in 5,700  -1 in 3,000  1 in 1,000 
Lipoprotein  1 in 9,400  -1 in 5,000  1 in 1,000 
* Extrapolated from data in Fig. 1 for the cell concentrations at which 37% of all cultures are not 
responding. 
* Assuming approximately 50% of all splenic lymphocytes to be B cells. 
§ As detected by IgM-PFC in the protein A-SRC plaque assay. 
secretion of IgM (7).  This result has been verified with the experiments reported 
in this paper. At present, we do not know whether LPS- and lipoprotein-reactive 
cells are the same, i.e.,  whether both mitogen receptors are present on each B 
cell, or whether two distinct subpopulations carry only one of the two mitogen 
receptors each. Therefore, at least every third B cell in spleen was analyzed in 
our frequency determinations.  This is the case if LPS and lipoprotein activate 
the same subpopulation of B cells. If  LPS and lipoprotein-reactive B cells belong, 
however,  to  two  different  B-cell  subpopulations,  then  we  have  analyzed the 
repertoire of two thirds of all B cells in the spleen.  We found that the absolute 
frequencies of anti-SRC and anti-TNP30 SRC B cells were the same among LPS- 
and lipoprotein-reactive cells.  If we activate two different subpopulations of B 
cells with LPS and lipoprotein, these results indicate that the v-gene repertoire 
is the same in two B-cell subsets. 
It has been suggested that T-cell-independent and T-cell-dependent antigens 
stimulate  different subpopulations  of B  cells to growth and  maturation to Ig 
secretion (12-14). This would mean that receptors for T-cell help are on different 
B  cells than the  mitogen receptors for the mitogenic principles of T-cell inde- 
pendent antigens, including LPS and lipoprotein. 1526  FREQUENCIES  OF  ANTIGEN-SPECIFIC  B  CELLS 
In this case our analyses of the repertoire of  Ig molecules produced by different 
B cells would be restricted to those B-cell subpopulations which recognize the 
mitogenic principle of LPS and/or lipoprotein in T-cell independent antigens. If, 
however, the same, LPS- and/or lipoprotein-reactive B cells can also be stimu- 
lated by T-cell help, then our repertoire analyses would also cover those B cells 
which simultaneously express receptors for T-cell help. 
How representative of the total repertoire of specificities are these frequency 
determinations? At present, there is no indication for a  selective expression of 
certain v  genes in different subpopulations  of B  cells, as defined by markers 
independent of Ig, in our case, the expression of a particular mitogen receptor. 
We, therefore, assume that our frequency determinations are representative of 
the total repertoire of Ig specificities. If not, it follows that none of the B-cell 
subsets, defined by functional reactivities to T-cell dependent or T-cell independ- 
ent antigens will be representative of the total repertoire. 
An experimental finding which suggests similarly high frequencies of specific 
B cells are the number of background PFC in normal mice. A  fraction of all 
spleen cells are large, Ig-secreting lymphocytes. These cells are detected in the 
hemolytic plaque  assay  as  background  PFC.  Whatever  the  origin  of these 
background PFC  is,  idiotype interactions,  B-cell stimulation by endogenous 
mitogens, or a  necessary process of terminal differentiation for some B  cells, 
they may be taken as representatives of the total repertoire of specificities, in 
the absence of overt antigenic priming. Table III shows the numbers of PFC in 
spleen of 6- to 8-wk old C3H/Tif mice, secreting IgM and secreting antibodies of 
the various specificities analyzed in our different plaque  assays. The relative 
frequencies of specific  antibody-producing cells  to  the total  number  of IgM 
producing cells are very similar to the absolute frequencies of mitogen-reactive 
B-cell precursors (compare Tables II and III). 
The frequencies of B cells producing antigen-binding Ig of different specifici- 
ties which we have determined for the LPS- and the lipoprotein-reactive popula- 
tions of B cells can be compared to frequency determinations for B cells produc- 
ing Ig binding to the same antigens detected with the same assays but under 
different experimental conditions for growth and maturation of B-cell clones. In 
vivo adoptive transfer of spleen cells often in the presence of antigen-primed T 
cells, into irradiated hosts, followed by challenge with antigen (15,  16) and in 
vitro Mishell-Dutton type (17) cultures of spleen cells in the presence of antigen- 
primed T cells in microcultures, again stimulated by antigen (13, 18) both yield 
50- to 100-fold lower frequencies for the number of B cells producing antigen- 
binding Ig. These differences in frequencies cannot be due to different sensitivi- 
ties in the assays, since in all experiments which we compare here, the same 
hemolytic plaque assays have been employed. In fact, for the detection of clones 
producing SRC-binding Ig we have used SRC from the very same sheep donor in 
practically the same plaque assay that was used in the frequency determina- 
tions of Quintans and Lefkovits (18-20)  in microcultures. 
We offer three explanations why our frequency determinations yield 50- to 
100-fold  higher numbers than do in vivo adoptive transfer experiments or in 
vitro Mishell-Dutton type microcultures. (a) We have determined frequencies 
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TABLZ III 
Specificity  of Background IgM PFC in Normal Spleen 
Plaque  assay 
Number of PFC per l0  s 
spleen cells* 
Ratio of specific PFC to 
total IgM-secreting 
PFC 
Protein A-SRC  10,000 
SRC  5  1 in 2,000 
NIP12SRC  300-600  1 in 16-32 
TNPsoSRC  50-100  1 in 100-200 
* 6- to 8-wk old C3H/Tif mice. 
initiate growth (7). In all previous studies of lymphocyte  responses in vitro, it is 
questionable whether all cells which actually had the capacity to be stimulated, 
did in fact initiate a response. This was largely due to the fact that growth could 
not be assessed by an increase in cell numbers, and B-cell maturation could not 
be measured by the total number of  Ig-secreting  cells. Therefore  the frequency  of 
stimulated clones could not be determined and thus the frequency of a defined 
specificity could not be corrected for plating efficiency. In our case, the absolute 
frequency of,  e.g.  anti-SRC  precursor B cells  -1/1000,  is corrected from the 
experimental value -1/6,000, by comparing it with the frequency of all spleen 
cells initiating growth and IgM secretion i.e. 1/e (Table II). As we have shown 
before, the fraction of all competent precursors which respond is largely depend- 
ent  on  the  culture  conditions  (1). The  anti-SRC  PFC  responses,  originally 
reported to be in the range of 5,000 PFC per culture (17), have recently been 
improved, in the very same system, by factors exceeding  50-fold (21). This, to us, 
indicates that a different number of precursor cells initiate a response. There- 
fore, it seems likely that the 50- to 100-fold differences in frequencies of SRC 
specific  B  cells determined in  Mishell-Dutton type systems (17) and in  our 
conditions are due to our better culture conditions. (b) As discussed above, we 
can assume separate subpopulations of B cells reactive to LPS/lipoprotein and to 
T-cell help, all possessing the same v-region repertoire. If T-cell help-reactive B 
cells are 50-100 times less frequent than are LPS/lipoprotein-reactive cells, then 
the frequency of any B-cell specificity will be accordingly 50-100 times lower. (c) 
In vivo adoptive transfer experiments and in vitro microcultures are dependent 
on the presence of antigen to elicit a response. Our experiments, therefore, differ 
basically in the mode of activation of B cells, not in the assays for the produced 
Ig molecules. It may be that activating the cell with a mitogen, and therefore 
bypassing the affinity-dependent  binding step of the antigen to the Ig receptors, 
we stimulate cells which secrete antibodies of high enough avidity to lyse the 
target erythrocytes, but  still  below the  affinity threshold for  activation.  It 
follows that the antigen-dependent activation step, in some instances, selects a 
lower number of antigen-binding cells for growth and maturation, while mito- 
gens, at their optimal concentration for B cells, always activate all cells. This 
explanation, however, is unlikely to account for a 50-fold difference in frequen- 
cies of specific B cells since the addition of LPS together with the antigen in the 1528  FREQUENCIES  OF  ANTIGENoSPECIFIC  B  CELLS 
Mishell-Dutton type of microculture experiments did not significantly change 
the frequencies of antigen-specific precursor B cells (19). 
An increasing number of LPS-stimulated, growing B-cell clones can be de- 
tected by plaque assays when the epitope density of haptenic determinants, 
whether TNP- or NIP-,  is increased on the SRC.  Multivalent binding to the 
haptenated SRC of Ig molecules with low affinity for the haptenic determinants 
is likely to occur more frequently  with increasing epitope densities. The frequen- 
cies of B cells producing Ig molecules binding to these haptenated SRC prepara- 
tions agree well with numbers of PFC  in mass cultures relative to the total 
number of PFC detected in the protein-A-SRC assay (1). The numbers of PFC in 
such mass cultures of mitogen-stimulated  B cells are, therefore, reasonable first 
estimates for the number of reactive, Ig-producing B cells detected by the given 
assay. The high frequencies of B cells detected with densely coupled TNP30 SRC 
or NIP12 SRC justify their previous use to detect polyclonal B-cell maturation (2, 
3, 6). It emphasizes how doubtful evaluations of antigen-specific responses must 
be which use these plaque assays (22-24). The definition of an antigen-specific 
response, thus, appears highly arbitrary. In antigen-stimulated responses speci- 
ficity is probed in the system at least on two levels: first during the activation of 
B cells and later, in the final assay, at the level of the effector function. This 
must make quantitative evaluations of specificity as the contributions of affini- 
ties  of interactions of sets  of v  regions with antigen to  B-cell  growth very 
difficult, if not impossible. Stimulating B cell by their growth-promoting mito- 
gens appears better for evaluations of the repertoire of B cells since quantita- 
tions depend solely on the assays. 
The surprisingly high frequencies of specific B cells appear to disagree with 
frequencies of serum antibody molecules with the same specificities within the 
total pool of natural serum Ig. If natural serum Ig constitutes a representative 
sample of the repertoire of all B cells,  we would expect from our experiment, 
e.g., one in every 1,000 Ig molecules in normal mouse serum to lyse SRC. At 
present we have no indications that this is so. Since, however, we measure only 
IgM antibodies which constitute less than 10% of all natural serum Ig, it may 
well be that the same high frequencies could be found in the IgM fraction of 
natural antibodies. This raises the possibility that repertoires of IgM- and of 
IgG-producing B cells are different. 
Summary 
The B-cell mitogens LPS and lipoprotein stimulate 20-35% of all B cells in the 
spleen of 6-  to  8-wk  old  C3H/Tif mice,  as  determined by  limiting dilution 
analysis of precursors. Each reactive cell grows to a clone of IgM-secreting PFC, 
enumerated in  a  hemolytic plaque  assay  detecting all  IgM  secreting cells, 
regardless of v-region specificity. We have used these mitogens to reveal the 
total repertoire ofIg specificities produced by these mitogen-reactive  B cells. We 
have determined in plaque assays with six different target erythrocytes the 
number of spleen cells limiting to one the number of mitogen-reactive B cells 
detected as specific IgM-secreting clones in each of these plaque assays. By this 
method,  the  absolute  frequencies of precursor  B  cells  with  defined v-gene 
specificities could be calculated, for at least, one third of all B cells. J.  ANDERSSON,  A.  COUTINHO,  AND  F.  MELCHERS  1529 
The frequencies of specific IgM-plaque-forming B-cell clones within the total 
pool of mitogen-reactive B  cells was 1 in 10 for NIPr,-SRC,  1 in 50 for TNP~o- 
SRC, 1 in 100 for NIP1-SRC, 1 in 160 for TNPz-SRC, 1 in 500 for HRC, and 1 in 
1,000 for SRC. These frequencies were the same in the LPS- and in the lipopro- 
tein-reactive B-cell population for TNP30- SRC and SRC. 
We thank Miss H. Campbell and Mrs. C. Giacometti  for able technical assistance. 
Received for publication 28 February 1977. 
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